Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.013 | 0.9 |